Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00921895 · ClinicalTrials.gov registry record · NA
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
A NA study, sponsored by Rapid Pathogen Screening.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT00921895 is a NA study that has completed, run by Rapid Pathogen Screening. The registered enrollment target is 128 participants.
The verdict
NCT00921895, a NA study, has completed, sponsored by Rapid Pathogen Screening.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
To engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofluorescence (CC-IFA). The polymerase chain reaction (PCR) will be used as a referee for discrepant cases.
Interventions
- DEVICE RPS Adeno Detector IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00921895
The ClinicalTrials.gov registry entry for NCT00921895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rapid Pathogen Screening, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RPS Adeno Detector IV is the first listed.
NCT00921895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00921895 about?
NCT00921895 is a clinical study titled "A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis". To engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofl...
What is the current status of trial NCT00921895?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2009-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00921895?
The interventions under investigation include: RPS Adeno Detector IV (DEVICE).
Who is sponsoring clinical trial NCT00921895?
This trial is sponsored by Rapid Pathogen Screening, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.